nasopharyngeal cancer
JUPITER-02 Findings Poised to Change Treatment Paradigm for Nasopharyngeal Carcinoma
The addition of the immunotherapy agent toripalimab (Coherus/Junshi Biosciences) to standard first-line ...
NOVEMBER 22, 2021
Weekly Cisplatin in Nasopharyngeal, Head & Neck Ca Questioned
In one phase 3 trial conducted in nasopharyngeal cancer and another conducted in head and neck cancer, there was no ...
SEPTEMBER 28, 2017
New Paradigm Proposed for Nasopharyngeal Cancer Rx
Chicago—Results from a Phase III trial in China support gemcitabine plus cisplatin as standard first-line ...
AUGUST 9, 2016
Load more